StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a report published on Tuesday. The brokerage issued a hold rating on the stock.
Milestone Scientific Stock Performance
MLSS stock opened at $0.57 on Tuesday. Milestone Scientific has a one year low of $0.52 and a one year high of $1.35. The firm has a 50-day moving average of $0.66 and a two-hundred day moving average of $0.71. The firm has a market capitalization of $43.77 million, a PE ratio of -5.71 and a beta of 0.97.
Milestone Scientific (NYSE:MLSS – Get Free Report) last issued its quarterly earnings results on Friday, March 29th. The company reported ($0.03) EPS for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%. The firm had revenue of $2.26 million during the quarter.
Institutional Investors Weigh In On Milestone Scientific
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical.
Featured Stories
- Five stocks we like better than Milestone Scientific
- What are earnings reports?
- Comprehensive PepsiCo Stock Analysis
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- CD Calculator: Certificate of Deposit Calculator
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.